Literature DB >> 10602486

Influence of promoter DNA topology on sequence-specific DNA binding and transactivation by tumor suppressor p53.

E Kim1, G Rohaly, S Heinrichs, D Gimnopoulos, H Meissner, W Deppert.   

Abstract

Transcriptional activation by the tumor suppressor p53 is regulated at multiple levels, including posttranslational modifications of the p53 protein, interaction of p53 with various regulatory proteins, or at the level of sequence-specific DNA binding to the response elements in p53's target genes. We here propose as an additional regulatory mechanism that the DNA topology of p53-responsive promoters may determine the interaction of p53 with its target genes. We demonstrate that sequence-specific DNA binding (SSDB) and transcriptional activation by p53 of the mdm2 promoter is inhibited when this promoter is present in supercoiled DNA, where it forms a non-B-DNA structure which spans the p53-responsive elements. Relaxation of the supercoiled DNA in vitro resulted in conversion of the non-B-DNA to a B-DNA conformation within the mdm2 promoter, and correlated with an enhanced SSDB of p53 and an elevated expression of a reporter gene. In contrast, sequence specific DNA binding and transcriptional activation of the p21 promoter were not inhibited by DNA supercoiling. We propose that conformational alterations within p53-responsive sites, which either promote or prohibit sequence specific DNA binding of p53, are an important feature in orchestrating the activation of different p53 responsive promoters.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10602486     DOI: 10.1038/sj.onc.1203139

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  13 in total

1.  Efficient specific DNA binding by p53 requires both its central and C-terminal domains as revealed by studies with high-mobility group 1 protein.

Authors:  Kristine McKinney; Carol Prives
Journal:  Mol Cell Biol       Date:  2002-10       Impact factor: 4.272

2.  SIRT1 contains N- and C-terminal regions that potentiate deacetylase activity.

Authors:  Min Pan; Hua Yuan; Michael Brent; Emily Chen Ding; Ronen Marmorstein
Journal:  J Biol Chem       Date:  2011-12-07       Impact factor: 5.157

3.  Rapid and Sensitive Detection of p53 Based on DNA-Protein Binding Interactions Using Silver Nanoparticle Films and Microwave Heating.

Authors:  Muzaffer Mohammed; Kadir Aslan
Journal:  Nano Biomed Eng       Date:  2014-11-10

4.  E2 ligase dRad6 regulates DMP53 turnover in Drosophila.

Authors:  Su Chen; Hui-Min Wei; Wen-Wen Lv; Da-Liang Wang; Fang-Lin Sun
Journal:  J Biol Chem       Date:  2011-01-04       Impact factor: 5.157

5.  Tracing the protectors path from the germ line to the genome.

Authors:  Daniel Coutandin; Horng Der Ou; Frank Löhr; Volker Dötsch
Journal:  Proc Natl Acad Sci U S A       Date:  2010-08-09       Impact factor: 11.205

Review 6.  Modes of p53 regulation.

Authors:  Jan-Philipp Kruse; Wei Gu
Journal:  Cell       Date:  2009-05-15       Impact factor: 41.582

Review 7.  Cruciform structures are a common DNA feature important for regulating biological processes.

Authors:  Václav Brázda; Rob C Laister; Eva B Jagelská; Cheryl Arrowsmith
Journal:  BMC Mol Biol       Date:  2011-08-05       Impact factor: 2.946

8.  Structural and dynamic basis of a supercoiling-responsive DNA element.

Authors:  Sung-Hun Bae; Sang Hoon Yun; Dawei Sun; Heon M Lim; Byong-Seok Choi
Journal:  Nucleic Acids Res       Date:  2006-01-09       Impact factor: 16.971

9.  Mutant p53 proteins bind DNA in a DNA structure-selective mode.

Authors:  Thomas Göhler; Stefan Jäger; Gabriele Warnecke; Hideyo Yasuda; Ella Kim; Wolfgang Deppert
Journal:  Nucleic Acids Res       Date:  2005-02-18       Impact factor: 16.971

10.  Preferential binding of hot spot mutant p53 proteins to supercoiled DNA in vitro and in cells.

Authors:  Marie Brázdová; Lucie Navrátilová; Vlastimil Tichý; Kateřina Němcová; Matej Lexa; Roman Hrstka; Petr Pečinka; Matej Adámik; Borivoj Vojtesek; Emil Paleček; Wolfgang Deppert; Miroslav Fojta
Journal:  PLoS One       Date:  2013-03-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.